A detailed history of Braidwell LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Braidwell LP holds 2,239,770 shares of OCUL stock, worth $18.7 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
2,239,770
Previous 1,643,770 36.26%
Holding current value
$18.7 Million
Previous $11.2 Billion 73.31%
% of portfolio
0.55%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.45 - $9.23 $3.84 Million - $5.5 Million
596,000 Added 36.26%
2,239,770 $19.5 Billion
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $6.9 Million - $14.3 Million
1,643,770 New
1,643,770 $11.2 Billion

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $641M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.